Publisher Correction: Detection of PD-L1 in the urine of patients with urothelial carcinoma of the bladder

被引：0
|
作者：
Georgi Tosev
Wasilijiang Wahafu
Philipp Reimold
Ivan Damgov
Constantin Schwab
Cem Aksoy
Adam Kaczorowski
Albrecht Stenzinger
Joanne Nyarangi‑Dix
Markus Hohenfellner
Stefan Duensing
机构：
[1] University Hospital Heidelberg,Department of Urology
[2] Chinese Academy of Medical Sciences and Peking Union Medical College,Department of Urology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital
[3] University of Heidelberg,Division of Pediatric Nephrology, Center for Pediatric and Adolescent Medicine
[4] University of Heidelberg,Institute of Medical Biometry and Informatics
[5] Heidelberg University Hospital,Department of General Pathology, Institute of Pathology
[6] University Hospital Heidelberg,Molecular Urooncology
来源：
Scientific Reports | / 11卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] PD-L1, PD-1 expression associated with clinicopathologic characteristics of patients with upper tract urothelial carcinoma
    Li, Pengchao
    Lu, Qiang
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2016, 23 : 44 - 44
  • [32] Predictive and Prognostic Role of PD-L1 in Urothelial Carcinoma Patients with Anti-PD-1/PD-L1 Therapy: A Systematic Review and Meta-Analysis
    Liu, Haoran
    Ye, Tao
    Yang, Xiaoqi
    Lv, Peng
    Wu, Xiaoliang
    Thou, Hui
    Lu, Hongyan
    Tang, Kun
    Ye, Zhangqun
    [J]. DISEASE MARKERS, 2020, 2020
  • [33] Evaluation of PD-L1 biomarker for immune checkpoint inhibitor (PD-1/PD-L1 inhibitors) treatments for urothelial carcinoma patients: A meta-analysis
    Rui, Xin
    Gu, Ting-Ting
    Pan, Hua-Feng
    Zhang, Hui-Zhi
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2019, 67 : 378 - 385
  • [34] PREDICTIVE AND PROGNOSTIC ROLE OF PD-L1 IN UROTHELIAL CARCINOMA PATIENTS WITH ANTI-PD-1/PD-L1 THERAPY: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Tang, Kun
    Jiang, Kehua
    Zhou, Hui
    Liu, Haoran
    Ye, Zhangqun
    Xu, Hua
    [J]. JOURNAL OF UROLOGY, 2018, 199 (04): : E1040 - E1040
  • [35] Analysis of real-world PD-L1 testing in patients with urothelial carcinoma.
    Krigsfeld, Gabriel S.
    Prince, Emily
    Zerba, Kim
    Chizhevsky, Vladislav
    Ragheb, Josette William
    Novotny, James
    White, James William
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [36] The value of PD-L1 immunohistochemical expression in Egyptian urinary bladder carcinoma patients
    Nor, Eman Mohamed Ahmed
    Saied, Eman Mohamed
    Alshenawy, Hanan Alsaeid
    Eldeen, Aliaa Atef Shams
    [J]. JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2023, 73 (04) : S118 - S123
  • [37] Expression and prognostic utility of PD-L1 in patients with squamous cell carcinoma of the bladder
    Owyong, Michael
    Lotan, Yair
    Kapur, Payal
    Panwar, Vandana
    McKenzie, Tiffani
    Lee, Thomas K.
    Zi, Xiaolin
    Martin, Jeremy W.
    Mosbah, Ahmed
    Abol-Enein, Hassan
    Ghoneim, Mohamed
    Youssef, Ramy F.
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2019, 37 (07) : 478 - 484
  • [38] Evaluation of PD-1 and PD-L1 expression in canine urothelial carcinoma cell lines
    Pinard, Christopher J.
    Hocker, Samuel E.
    Poon, Andrew C.
    Inkol, Jordon M.
    Matsuyama, Arata
    Wood, R. Darren
    Wood, Geoffrey A.
    Woods, J. Paul
    Mutsaers, Anthony J.
    [J]. VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 2022, 243
  • [39] Prognostic value of PD-1/PD-L1 expression in upper tract urothelial carcinoma
    Campedel, L.
    Seisen, T.
    Cussenot, O.
    Comperat, E.
    Varinot, J.
    Roupret, M.
    Cancel-Tassin, G.
    [J]. PROGRES EN UROLOGIE, 2018, 28 (16): : 900 - 905
  • [40] Research progress on PD-1 and PD-L1 inhibitors in the treatment of metastatic urothelial carcinoma
    Tang, Quanqing
    Li, Shihao
    Huang, Gaozhen
    Liu, Hongwei
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 119
12345